Regenxbio RGNX
NASDAQ RGNX
$7.42 -0.11 (-1.46%)
At close: Oct 1, 2026 · 4:00 PM EDT

Regenxbio (RGNX) Preferred Dividend Payments (2014 - 2015)

Updated

Regenxbio (RGNX) reported Preferred Dividend Payments of $1.75 million for FY2015, up 114.4% from $815,000 in FY2014.

Analysis

Regenxbio (RGNX) Preferred Dividend Payments (2014 - 2015) Analysis & Trends

  • According to Business Quant data, Preferred Dividend Payments came in at $815,000 in FY2014 (+93.1%) and $422,000 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Regenxbio 407.85 Mn -525.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 2.50 Mn
Mar 31, 2015 -755,000.00
Dec 31, 2014 223,000.00
Sep 30, 2014 126,000.00
API Access

Regenxbio Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=RGNX&period=max&api_key=YOUR_API_KEY